Japanese Pharmaceuticals & Biotech Price disconnect

Results

0 new

Stocks which the market has priced substantially different to their cash flows, which could imply risk.

2 companies

Astellas Pharma

Market Cap: JP¥4.0t

Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

4503

JP¥2,208.00

1.7%

59.8%

Sumitomo Pharma

Market Cap: JP¥696.7b

Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.

4506

JP¥1,553.00

1.6%

71.4%